Penserra Capital Management LLC Cyma Bay Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$3.23 - $4.6 $5,103 - $7,267	-1,580 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.47 - $4.42 $34 - $44	10 Added 0.64%	1,580 $5,000
Q2 2021 Aug 12, 2021	SELL	$3.94 - $4.92 $98 - $123	-25 Reduced 1.57%	1,570 $6,000
Q1 2021 May 13, 2021	BUY	$4.23 - $6.55 $63 - $98	15 Added 0.95%	1,595 $7,000
Q4 2020 Feb 12, 2021	BUY	$5.73 - $9.03 $5,695 - $8,975	994 Added 169.62%	1,580 $9,000

Q3 2020 Nov 13, 2020	BUY	$3.32 - $7.24 $1,945 - $4,242	586 New	586 $4,000

1.88M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.